Shaywitz BA - Search Results

1

Aspartame and seizure susceptibility: results of a clinical study in reportedly sensitive individuals.

Rowan AJ, Shaywitz BA, Tuchman L, French JA, Luciano D, Sullivan CM. Rowan AJ, et al. Among authors: shaywitz ba. Epilepsia. 1995 Mar;36(3):270-5. doi: 10.1111/j.1528-1157.1995.tb00995.x. Epilepsia. 1995. PMID: 7614911 Clinical Trial.

2

Aspartame, behavior, and cognitive function in children with attention deficit disorder.

Shaywitz BA, Sullivan CM, Anderson GM, Gillespie SM, Sullivan B, Shaywitz SE. Shaywitz BA, et al. Among authors: shaywitz se. Pediatrics. 1994 Jan;93(1):70-5. Pediatrics. 1994. PMID: 7505423 Clinical Trial.

3

Aspartame has no effect on seizures or epileptiform discharges in epileptic children.

Shaywitz BA, Anderson GM, Novotny EJ, Ebersole JS, Sullivan CM, Gillespie SM. Shaywitz BA, et al. Ann Neurol. 1994 Jan;35(1):98-103. doi: 10.1002/ana.410350115. Ann Neurol. 1994. PMID: 7506878 Clinical Trial.

4

Aspartame: review of safety.

Butchko HH, Stargel WW, Comer CP, Mayhew DA, Benninger C, Blackburn GL, de Sonneville LM, Geha RS, Hertelendy Z, Koestner A, Leon AS, Liepa GU, McMartin KE, Mendenhall CL, Munro IC, Novotny EJ, Renwick AG, Schiffman SS, Schomer DL, Shaywitz BA, Spiers PA, Tephly TR, Thomas JA, Trefz FK. Butchko HH, et al. Among authors: shaywitz ba. Regul Toxicol Pharmacol. 2002 Apr;35(2 Pt 2):S1-93. doi: 10.1006/rtph.2002.1542. Regul Toxicol Pharmacol. 2002. PMID: 12180494 Review.

5

Aspartame and seizures.

Shaywitz BA, Novotny EJ Jr. Shaywitz BA, et al. Neurology. 1993 Mar;43(3 Pt 1):630-1. doi: 10.1212/wnl.43.3_part_1.630. Neurology. 1993. PMID: 8451019 No abstract available.

6

Science informing policy: The National Institute of Child Health and Human Development's contribution to reading.

Shaywitz SE, Shaywitz BA. Shaywitz SE, et al. Among authors: shaywitz ba. Pediatrics. 2002 Mar;109(3):519-21. doi: 10.1542/peds.109.3.519. Pediatrics. 2002. PMID: 11875152 No abstract available.

7

Comorbidity: a critical issue in attention deficit disorder.

Shaywitz BA, Shaywitz SE. Shaywitz BA, et al. Among authors: shaywitz se. J Child Neurol. 1991;6 Suppl:S13-22. doi: 10.1177/0883073891006001s03. J Child Neurol. 1991. PMID: 2002212 Review.

8

Introduction to the special series on attention deficit disorder.

Shaywitz SE, Shaywitz BA. Shaywitz SE, et al. Among authors: shaywitz ba. J Learn Disabil. 1991 Feb;24(2):68-71. doi: 10.1177/002221949102400202. J Learn Disabil. 1991. PMID: 2010676 No abstract available.

9

Growth hormone and prolactin response to methylphenidate in children with attention deficit disorder.

Shaywitz BA, Shaywitz SE, Sebrechts MM, Anderson GM, Cohen DJ, Jatlow P, Young JG. Shaywitz BA, et al. Among authors: shaywitz se. Life Sci. 1990;46(9):625-33. doi: 10.1016/0024-3205(90)90131-a. Life Sci. 1990. PMID: 2308471 Free article. Clinical Trial.

10

Increased medication use in attention-deficit hyperactivity disorder: regressive or appropriate?

Shaywitz SE, Shaywitz BA. Shaywitz SE, et al. Among authors: shaywitz ba. JAMA. 1988 Oct 21;260(15):2270-2. JAMA. 1988. PMID: 3050168 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

214 results

Search Page

Filters